After Patient Death, FDA Warns Of Risks Of Fecal Transplantation

After a patient died and another developed an invasive infection from fecal microbiota transplantation (FMT) treatment, which is not approved by FDA, the agency issued a safety alert urging health care providers to communicate the risks of the treatment to their patients, and to test stool donors and stool samples for multi-drug resistant organisms (MDROs) before use. The donor stool samples that caused the patient death and infection were not tested before use, FDA said. FDA biologics center director Peter...